Assemblies for in vitro measurement of bioadhesive strength and retention characteristics in simulated vaginal environment.
The vaginal route of administration offers a promising option for local and systemic delivery of drugs. Conventional vaginal formulations are associated with limitations of poor retention, leakage, and messiness, thereby causing inconvenience to users. To overcome these limitations, formulations that adhere to the vaginal mucosa for a sufficient period of time need to be developed. Bioadhesion and retention are desirable characteristics of a vaginal formulation to achieve desired efficacy. These properties can be built in during formulation development by the use of bioadhesive polymers. In the present study, assemblies for in vitro measurement of bioadhesive strength and retention characteristics of vaginal formulations have been developed. A modified simulated vaginal fluid (SVFM) was used to simulate vaginal conditions for bioadhesion studies. Cellophane hydrated with SVFM and isolated sheep vaginal mucosa were used as model membranes. The bioadhesive potential of various polymers and their combinations was evaluated. Among the polymers evaluated, xanthan gum (XG), sodium alginate (SA), Polycarbophil (PC), and their combinations (XG + SA and XG + PC) were found to possess significant bioadhesive strength. In retention experiments, XG, SA, and combinations (XG + SA and XG + PC) were retained in isolated sheep vaginal tissue, while PC exhibited poor retention under experimental conditions. Based on the results of the study conducted, XG, SA, and combinations (XG + SA and XG + PC) have been proposed as potential candidates for developing bioadhesive vaginal drug delivery systems.
Vermani
Kavita
K
National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Punjab 160062, India.
Garg
Sanjay
S
Zaneveld
Lourens J D
LJ
D000179:Acrylates / Q000737:chemistry / Q000494:pharmacology; D000180:Acrylic Resins / Q000737:chemistry / Q000494:pharmacology; D000268:Adhesiveness / Q000187:drug effects; D000282:Administration, Intravaginal; D000464:Alginates / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D002686:Chitin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D048271:Chitosan; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004867:Equipment Design; D005260:Female; D005782:Gels; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D066298:In Vitro Techniques; D008567:Membranes, Artificial; D009092:Mucous Membrane; D011108:Polymers / Q000737:chemistry* / Q000494:pharmacology; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000494:pharmacology; D033081:Shear Strength; D012756:Sheep; D013678:Technology, Pharmaceutical / Q000295:instrumentation*; D013718:Tensile Strength; D014621:Vagina / Q000187:drug effects*
D000179:Acrylates; D000180:Acrylic Resins; D000464:Alginates; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005782:Gels; D006603:Hexuronic Acids; D008567:Membranes, Artificial; D011108:Polymers; D011135:Polysaccharides, Bacterial; D002686:Chitin; D020723:Glucuronic Acid; C030312:calcium polycarbophil; D048271:Chitosan; C453622:carbopol 934P; C002563:xanthan gum